GlassScriptPhysician profile
Joel C Hall
NPI 1982686986
$1,955.28
in general payments reported to CMS, 2019-2025
23 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $53.38 · 2021: $713 · 2022: $143 · 2023: $385 · 2024: $184 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $402.57 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $244.04 | 2021 | |
| Astellas Pharma US INC | $197.83 | 2023-2025 | Veozah |
| Amgen INC. | $184.56 | 2019-2023 | Evenity, Prolia |
| Zimmer Biomet Holdings, INC. | $149.63 | 2021 | |
| Hologic Sales and Service, LLC | $130.22 | 2023-2025 | Aptima, Acessa Provu System, Novasure |
| Pfizer INC. | $122.58 | 2019-2023 | |
| Ethicon US, LLC | $113.20 | 2022-2025 | Vistaseal, Evarrest |
| Bayer Healthcare Pharmaceuticals INC. | $99.44 | 2019-2023 | |
| Novo Nordisk INC | $46.20 | 2023-2025 | Wegovy |
| Therapeuticsmd, INC. | $34.81 | 2021-2022 | |
| Millicent US INC | $32.72 | 2025 | Femlyv |
| Evofem Biosciences, INC. | $32.24 | 2021 | |
| Radius Health, INC. | $24.57 | 2024 | Tymlos |
| Coloplast Corp | $21.06 | 2023 | Saffron |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $20.74 | 2019 | |
| Solventum Corporation | $16.58 | 2025 | Prevena |
| Aspira Women'S Health INC | $16.08 | 2024 | Ova1 |
| Takeda Pharmaceuticals U.S.A., INC. | $15.80 | 2021 | |
| Smith+Nephew, INC. | $14.30 | 2025 | Pico |
| Organon LLC | $13.43 | 2025 | Jada System |
| Biohaven Pharmaceuticals, INC. | $11.44 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.